Welcome to LookChem.com Sign In|Join Free
  • or
(3-methoxyphenyl)(pyridin-2-yl)methanamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

95899-02-8

Post Buying Request

95899-02-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

95899-02-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 95899-02-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,8,9 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 95899-02:
(7*9)+(6*5)+(5*8)+(4*9)+(3*9)+(2*0)+(1*2)=198
198 % 10 = 8
So 95899-02-8 is a valid CAS Registry Number.

95899-02-8Relevant academic research and scientific papers

Construction and regulation of imidazo[1,5-a]pyridines with AIE characteristics via iodine mediated Csp2?H or Csp?H amination

Zhang, Jun,She, Mengyao,Liu, Lang,Liu, Mengdi,Wang, Zhaohui,Liu, Hua,Sun, Wei,Liu, Xiaogang,Liu, Ping,Zhang, Shengyong,Li, Jianli

supporting information, p. 3083 - 3086 (2021/06/28)

The widespread applications of aggregation-induced emission luminogens (AIEgens) inspire the creation of AIEgens with novel structures and functionalities. In this work, we focused on the direct and efficient synthesis of a new type of AIEgens, imidazo[1,5-a]pyridicne derivatives, via iodine mediated cascade oxidative Csp2–H or Csp–H amination route from phenylacetylene or styrenes under mild conditions. The resulted compounds showed excellent AIE characteristics with tunable maximum emissions, attractive bioimaging performance, and potential anti-inflammatory activity, which exert broad application prospects in material, biology, medicine, and other relevant areas.

DOPAMINE D2 RECEPTOR LIGANDS

-

Page/Page column 115; 117; 125; 126; 127, (2016/07/05)

The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 95899-02-8